Med Gen Gets Nod from Russia
Thursday March 13, 8:06 am ET
BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (OTCBB:MGEN - News) (“MGEN”), manufacturers of nationally branded OTC healthier life products and specialty financial services, announced today that it has received the approval from its distributor, CH Laboratories, to ship both Snorenz® and Painenz® into Russia.
“The potential business is substantial,” said Paul Mitchell, company President. “After a year and a trip to Russia, it’s all worth while.” The products will be shipped under the brand name Sonergy and sampling will begin as early as next week.
“Grinding out the International Business Plan for the company is a slow process, but we have stuck with it, paid the costs and we will enjoy the prosperity that these new shipping avenues have presented. China is next in line and approval is expected shortly,” said Paul Kravitz, Chairman.
About Med Gen Inc.
Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray’s the Way (“STW”). It is best known for producing the world’s first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the UnDiet® system into its family of brands. Fab U lust™, the company’s newest product, a female sexual stimulant, has been launched in test markets through out the country. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty financial and investment services to small emerging public companies through its Financial Services Division.
Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol “MGEN”. For information contact Investor Relations 561-750-1100 or www.medgen.com.
This Press Release contains or incorporates by reference “forward-looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward-looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
Contact:
Med Gen Inc., Boca Raton
Paul Kravitz, 561-750-1100
www.medgen.com
--------------------------------------------------------------------------------
Source: Med Gen Inc.
News 
Market Data 
Discover 
